Mother Nature's Remedy
The parent herbal project. Current surfaces include Docta and Spiritual-Search. MNR owns the safety posture: peer-reviewed evidence first, regulatory sources second, anecdote/tradition clearly labeled.
What we know so far
The foundation
Shopify herbalist assistant
A floating storefront widget with OpenAI guidance, product recommendations, and a HeyGen avatar proxy. Recent work expanded protocol language, so claims and interaction guardrails are the immediate priority.
Separate R&D lane
Botanica now has its own project folder, plan, tickets, research queue, and formula-draft space. It borrows MNR's research standards but tracks its own formula roadmap.
Operating thesis
“Felt, not filler” — translated safely.
The creative goal is distinctive, experiential botanical products. The compliance translation is: no disease claims, no prescription-drug equivalence, no guaranteed effects, no consumer dosing directions, and no high-risk stack without research review. Every concept below is a hypothesis, not a recommendation.
Forever alive
Research Pulse
A living feed of the strongest research, regulatory, safety, and industry signals Botanica is tracking.
Clickable research desk
News, citations, and niche deep dives
Open a topic to read the Botanica take, blend ideas, safety flags, and linked source trail.
Best current remedies
Remedy Atlas
The strongest current formulation directions, ranked by product promise, evidence quality, and safety/compliance feasibility.
What Botanica watches
Living watchlist
Formula lab
Possible blend ideas
Filtered by target state. These are internal R&D concepts with evidence notes and risk flags, not medical advice or finished product claims.
Talk to the formulator
Botanica Lab Bot
An open-ended creative formulation bot for exploring botanical blend concepts. Ask for a target state, format, flavor direction, ingredient theme, or potency level and it will brainstorm combinations with safety review flags.
Checking chat mode…
Guardrails
Claims and safety architecture
Language to use internally
- “Target state” instead of disease treatment.
- “Formulation hypothesis” instead of protocol.
- “Candidate ingredient range needs review” instead of dosing instructions.
- “Evidence quality: peer-reviewed / traditional / anecdotal / unknown.”
Language to avoid publicly
- Prescription analogues such as “Adderall-like,” “Xanax-class,” or “MDMA-like.”
- Claims to diagnose, treat, cure, prevent, or mitigate disease.
- Guaranteed onset, guaranteed effect, or “works for everyone.”
- Unreviewed contraindication or drug-interaction guidance.
Mandatory review flags
- Mood, anxiety, sleep, hormones, pain, pregnancy, liver risk.
- Anticoagulants, sedatives, stimulants, SSRIs/SNRIs/MAOIs, CYP interactions.
- High-potency extracts, obscure botanicals, or stacked actives.
- Any consumer-facing copy or formula launch decision.
Evidence anchors
Research notes powering the first pass
The full claims review is still open. These anchors are included so the site is transparent about where early assumptions came from.
FTC Health Products Compliance Guidance — advertising must be truthful, non-misleading, and substantiated by competent and reliable scientific evidence.
FDA Questions & Answers on Dietary Supplements — supplements are not pre-approved by FDA before marketing; firms are responsible for lawful labeling and safety.
Saffron mood evidence — 2026 GRADE-assessed systematic review/meta-analysis of 34 randomized controlled trials.
Rhodiola fatigue evidence — 2012 systematic review on physical and mental fatigue.
Kava safety evidence — systematic review focused on safety in anxiety studies; liver/sedation risk still requires conservative handling.
L-theanine + caffeine attention literature — current RCT/meta-analysis trail for attention and mood in healthy participants.
Execution path
What happens next
- Living scan. Run the daily autonomous research pulse and keep the site fresh.
- Safety review. Finish Botanica agent claims/safety review before consumer-facing usage.
- MVP format. Expand one-formula-at-a-time output into both cards and the Lab Bot: target state, mechanism, candidates, safety flags, evidence anchors.
- Chat upgrade. Wire Lab Bot to a secure backend LLM/proxy if Armon wants true open-ended AI conversation beyond the static rules engine.
- First research brief. Pick one high-potential formula and run MNR-style evidence review.
- Design decision. Decide if Botanica stays on-demand or gets its own planner/researcher/worker trio.